immune response to tirzepatide GLP-1R agonist therapy and vaccine response: Neglected implications Shifting the Scales: Tirzepatide's Breakthrough

Autoimmune disorders have ties to inflammation in the body

"After the first half year the amount of wight loss may slow down, reaching maximum weight loss at about one year of continuous use, but you then need to keep taking the drug in a sufficient dose." While the effectiveness of semaglutide in the very-long term is unclearas the drugs are relatively new on the marketThomsen said some patients may need to keep taking semaglutide indefinitely

Key results: Mean weight loss: 20.2% with tirzepatide vs

doi: 10.1111/dom.14496 8 AndersenDBHolstJJ

2023131 GLP-118 0.36mg6 1/29) 1 GLP-1 () 3 GLP-1 30 301 GLP-1 () GLP-1 GLP-1